Dr. Patrick Wen, MD

• Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Harvard Longwood Neurology Prg

  Residency Hospital

• London Chest Hospital London

  Residency Hospital

• Nat'l Hospital Nervous Diseasesuk

  Residency Hospital

• Whittington Hospital London

  Residency Hospital

• North Middlesex Hospital London

  Internship Hospital

• St Bartholomew's London Uk

  Internship Hospital

• St Bartholomews Hospital

  Internship Hospital, 1982

• University Of London Faculty Of Med

  Medical School, 1981

• English

• Cantonese

• Mechanisms and therapeutic implications of hypermutation in gliomas, 2020-04-15

• Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss, 2009-10-06

• Prospective, high-throughput molecular profiling of human gliomas, 2012-07-22

• Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors, 2015-08-17

• Preclinical efficacy of the MDM2 inhibitor RG7112 inMDM2amplified andTP53wild-type glioblastomas, 2015-10-19

• Clinical, radiological and genomic features and targeted therapy inBRAFV600E mutant adult glioblastoma, 2021-03-01

• Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas, 2011-01-19

• Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma, 2010-05-13

• Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial, 2018-12-19

• DNA Fragmentation Simulation Method (FSM) and Fragment Size Matching Improve aCGH Performance of FFPE Tissues, 2012-06-15

• Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma, 2022-08-16

• Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade, 2018-11-27

• Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti-angiogenic Therapy, 2013-08-18

• Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma, 2014-09-09

• A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients, 2015-04-24

• It Is Time To Include Brain Tumor Patients in Phase I Trials in Oncology, 2011-07-18

• Myeloid Biomarkers Associated with Glioblastoma Response to Anti-Vascular Endothelial Growth Factor Therapy with Aflibercept, 2011-06-01